Bio-Rad Introduces new Pro-Human Diabetes Assay Panel
News Jun 24, 2008
Bio-Rad Laboratories, Inc. has announced new Bio-Plex Pro™ Human Diabetes Assay Panels for Bio-Rad’s Bio-Plex® suspension array system.
Offered as one multiplex and two singleplex assays designed to achieve optimal working assay ranges, the new pro-human diabetes assay can deliver accurate and reproducible multiplex measurements of human diabetes and obesity markers, the company claims.
• The pro-human assay panel consists of a premixed 12-plex of analytes (C-Peptide, ghrelin, GIP, and visfatin) thataGLP-1, glucagon, IL6, insulin, leptin, PAi-1, resistin, TNF- work with magnetic beads, pre-blended detection antibodies, standards and controls. The singleplex assays (adiponectin and adipsin) may be mixed together to form a 2-plex assay.
• The reagent kit includes an assay buffer, wash buffer, streptavidin-PE, 96-well filter plate, sealing tape, and panel specific instructions required to prepare assays and acquire data.
• The diluents kit can enable the researcher to choose the appropriate diluents kit for diluting samples, standards and controls.
All three Bio-Plex pro-human diabetes assays were validated using real patient samples.
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017